Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
152.55
+3.56 (2.39%)
At close: Aug 21, 2026, 4:00 PM EDT
153.49
+0.94 (0.62%)
After-hours: Aug 21, 2026, 7:59 PM EDT

Merck & Co. Revenue

Merck & Co. had revenue of $16.61B in the quarter ending June 30, 2026, with 5.07% growth. This brings the company's revenue in the last twelve months to $66.57B, up 4.64% year-over-year. In the year 2025, Merck & Co. had annual revenue of $65.01B with 1.31% growth.

Revenue (ttm)
$66.57B
Revenue Growth
+4.64%
P/S Ratio
5.65
Revenue / Employee
$887,587
Employees
75,000
Market Cap
376.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.01B843.00M1.31%
Dec 31, 202464.17B4.05B6.74%
Dec 31, 202360.12B832.00M1.40%
Dec 31, 202259.28B10.58B21.72%
Dec 31, 202148.70B7.19B17.31%
Dec 31, 202041.52B2.40B6.13%
Dec 31, 201939.12B-3.17B-7.50%
Dec 31, 201842.29B2.17B5.41%
Dec 31, 201740.12B315.00M0.79%
Dec 31, 201639.81B309.00M0.78%
Dec 31, 201539.50B-2.74B-6.48%
Dec 31, 201442.24B-1.80B-4.08%
Dec 31, 201344.03B-3.23B-6.84%
Dec 31, 201247.27B-780.00M-1.62%
Dec 31, 201148.05B2.06B4.48%
Dec 31, 201045.99B18.56B67.66%
Dec 31, 200927.43B3.58B15.00%
Dec 31, 200823.85B-347.70M-1.44%
Dec 31, 200724.20B13.60B128.41%
Dec 31, 200610.59B1.09B11.42%
Dec 31, 20059.51B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson97.93B
Eli Lilly and Company79.67B
AbbVie64.39B
Pfizer63.70B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi55.89B
Novo Nordisk50.34B
Revenue Rankings